National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
Send to Printer
Gestational Trophoblastic Tumors Treatment (PDQ®)     
Last Modified: 12/05/2007
Health Professional Version
Placental-Site Gestational Trophoblastic Tumors

Current Clinical Trials

Hysterectomy is the treatment of choice for patients with placental-site trophoblastic tumors. Although most reports have noted a benign course for these tumors, they are relatively resistant to chemotherapy and can be fatal.[1]

Current Clinical Trials

Check for U.S. clinical trials from NCI's PDQ Cancer Clinical Trials Registry that are now accepting patients with placental-site gestational trophoblastic tumor 1. The list of clinical trials can be further narrowed by location, drug, intervention, and other criteria.

General information about clinical trials is also available from the NCI Web site 2.

References

  1. Lurain JR: Gestational trophoblastic tumors. Semin Surg Oncol 6 (6): 347-53, 1990.  [PUBMED Abstract]


Table of Links

1http://www.cancer.gov/Search/ClinicalTrialsLink.aspx?Diagnosis=41357&tt=1&a
mp;format=2&cn=1
2http://www.cancer.gov/clinicaltrials